Myasthenia gravis (MG) is a rare nerve-muscle disease characterized by muscle weakness and fatigue . The disease occurs when the communication between nerve cells and the body's muscles is disrupted . This breakdown is typically due to immune factors attacking the junction where nerves and muscles meet – the neuromuscular synapse . Consequently,

Ketoconazole serves as a leading antifungal compound. This potent therapy effectively disrupts a wide variety of fungal infections, constituting it a crucial resource in the fight against these detrimental conditions. Its capacity to suppress ergosterol biosynthesis, a critical component of fungal cell membranes, results in significant reduction of